Vol 7, No 6 (December 01, 2018): Chinese Clinical Oncology (Neoadjuvant Therapy for Ovarian Cancer)

Preface on Neoadjuvant Therapy for Ovarian Cancer1

Neoadjuvant therapy for ovarian cancer
Evgeny Imyanitov
Chinese Clinical Oncology  
2018;
7
(6)
:54
.

Review Article on Neoadjuvant Therapy for Ovarian Cancer1

Neoadjuvant therapy: theoretical, biological and medical consideration
Evgeny N. Imyanitov, Grigoriy A. Yanus
Chinese Clinical Oncology  
2018;
7
(6)
:55
.
Principles of clinical management of ovarian cancer
Tatiana V. Gorodnova, Anna P. Sokolenko, Ekatherina Kuligina, Igor V. Berlev, Evgeny N. Imyanitov
Chinese Clinical Oncology  
2018;
7
(6)
:56
.
Neoadjuvant chemotherapy and interval debulking surgery for advanced ovarian cancer, an alternative with multiple advantages
Heriberto Medina-Franco, Lorelí Mejía-Fernández
Chinese Clinical Oncology  
2018;
7
(6)
:57
.
Neoadjuvant chemotherapy in advanced ovarian cancer: optimal patient selection and response evaluation
Jae Hyun Cho, Seik Kim, Yong Sang Song
Chinese Clinical Oncology  
2018;
7
(6)
:58
.
Pathological response of ovarian cancer to neoadjuvant chemotherapy
Alexandr O. Ivantsov
Chinese Clinical Oncology  
2018;
7
(6)
:59
.

Original Article

Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas
Thomas Ohnleiter, Delphine Antoni, François Lefebvre, Pierre Truntzer, Philippe Schultz, Mickael Burgy, Christian Borel, Georges Noël
Chinese Clinical Oncology  
2018;
7
(6)
:60
.

Review Article

Immunotherapy: a glimmer of hope for metastatic prostate cancer
Vishal Jindal
Chinese Clinical Oncology  
2018;
7
(6)
:61
.

Case Report

Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case report
Bixia Tang, Xinan Sheng, Yan Kong, Zhihong Chi, Lu Si, Chuanliang Cui, Xieqiao Yan, Lili Mao, Bin Lian, Siming Li, Xuan Wang, Jie Dai, Xue Bai, Li Zhou, Jun Guo
Chinese Clinical Oncology  
2018;
7
(6)
:62
.

Meet the Professor2

Douglas G. McNeel: stay current reading research literature, there is no substitute for hard work!
Brad Li
Chinese Clinical Oncology  
2018;
7
(6)
:63
.

Disclosure:

1. The series “Neoadjuvant Therapy for Ovarian Cancer” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Evgeny Imyanitov served as the unpaid Guest Editor for the series.

2. The series “Meet the Professor” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding.